Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis
Status:
Terminated
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to:
1. To evaluate the latest effects of TW for IgA nephropathy (IgAN) with asymptomatic
abnormal urinalysis.
2. To evaluate the safety and tolerability of TW.